LIVE VIEW · LGNDLIGAND PHARMACEUTICALS INCHealthcareLGND research Sign up to open the full interactive terminal, save boards, and get alerts
LGND · Live chart
Loading live chart
LGND · Smart-money compositeas of Jul 30
-25SHORTsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsSHORT
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
LGND · Recent signals
D. E. Shaw & Co., Inc. cut 71% of LGND (2026Q1)HIGHSHORTJul 24
D. E. Shaw & Co., Inc. added +932% to LGND (2026Q1)HIGHLONGJul 24
Q1-2026: Missed consensus by 12.0% - EPS $1.63 vs $1.852 estimateMEDIUMSHORTJun 19
Q2-2025: Beat consensus by 10.4% - EPS $1.6 vs $1.4499 estimateMEDIUMLONGJun 16
Missed consensus by 12.0% - EPS $1.63 vs $1.852 estimateMEDIUMSHORTJun 16
Q3-2025: Beat consensus by 57.3% - EPS $3.09 vs $1.9642 estimateMEDIUMLONGJun 16
Q4-2025: Beat consensus by 26.8% - EPS $2.02 vs $1.5926 estimateMEDIUMLONGJun 16
LGND · Institutional holdersas of 2025Q3
Point72 Asset Management, L.P.$3.0Mn/a
D. E. Shaw & Co., Inc.$1.4M+375.0%
CITADEL ADVISORS LLC$808Kn/a
Bridgewater Associates, LP$795K+226.6%
CITADEL ADVISORS LLC$662K-23.2%
D. E. Shaw & Co., Inc.$439K-71.1%
D. E. Shaw & Co., Inc.$283Kn/a
Bridgewater Associates, LP$228Kn/a
Live alerts on LGND
Live alerts on LGNDGet pinged the moment insiders, congress, or 13F funds move on LGND.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for LGND.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock